Pharmacokinetics of oral glyburide in subjects with non-insulin- dependent diabetes mellitus and renal failure

American Journal of Kidney Diseases

Volumn 29, Issue 6, 1997, Pages 907-911

  Brier, Michael E ^a   Bays, Harold ^b   Sloan, Rebecca ^b   Stalker, Dennis J ^b   Welshman, Ian ^b   Aronoff, George R ^b  

^a Baxter Biomedical Science Building   (United States)

^b NONE

Author keywords

Glyburide; Pharmacodynamics; Pharmacokinetics

Indexed keywords

GLIBENCLAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE DIET; CLINICAL ARTICLE; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

EID: 0031005955     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90465-0     Document Type: Article

References (14)

1. Bennett WM, Aronoff GR, Golper TA, Morrison G, Singer I, Brater DC: Drug prescribing in renal failure: Dosing guidelines for adults. Am J Kidney Dis 3:155-193, 1983
2. Rosenkranz B, Malerczyk V, Lehr KH, Ringoir S, Lameire KH, Metelko S, Profozic V: Kinetics and efficacy of glimepiride in diabetic subjects with kidney disease. Clin Pharmacol Ther 55:207, 1994
3. Pearson JG, Antal EJ, Raehl CL, Gorsch HK, Craig WA, Albert KS, Welling PG: Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function. Clin Pharmacol Ther 39:318-324, 1986
4. Feldman JM: Glyburide: A second-generation sulfonylurea hypoglycemic agent. Pharmacotherapy 5:43-62, 1985
5. Nieder M, Dilger C, Jaeger H: Determinations of glibenclamide in human serum by high performance liquid chromatography. J High Res Chromatogr Commun 9:102-105, 1986
6. Coppack SW, Lant AF, McIntosh CS, Rodgers AV: Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. Br J Clin Pharmacol 29:673-684, 1990
7. Jönsson A, Hallengren B, Rydberg T, Melander A, Ekberg G: Slow elimination of glyburide in NIDDM subjects. Diabetes Care 17:142-145, 1994
8. Jaber LA, Slaughter RL, Antal EJ, Welshman IR: Comparison of pharmacokinetics and pharmacodynamics of short-and long-term glyburide therapy in NIDDM. Diabetes Care 17:1300-1306, 1994
9. Peart GF, Shenfield GM: The metabolism of glyburide in subjects of known debrisoquin phenotype. Clin Pharmacol Ther 45:277-284, 1989
10. Reidenberg MM: The biotransformation of drugs in renal failure. Am J Med 62:482-485, 1977
11. Touchette MA, Slaghter RL: The effect of renal failure on hepatic drug clearance. DICP 25:1214-1224, 1991
12. Rydberg T, Røder M, Jönsson A, Melander A: Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care 17:1026-1030, 1994
13. Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA: Splanchnic and renal metabolism of insulin in human subjects: A dose response study. Am J Physiol 244 (Endocrinol Metab 7): E517-E527, 1983
14. Chamberlain MJ, Stimmler L: The renal handling of insulin. J Clin Invest 46:911-919, 1967